5 May 2016 - PHARMAC invites proposals for the supply of anti-vascular endothelial growth factor agents in New Zealand.

PHARMAC is interested in considering proposals from suppliers of anti-vascular endothelial growth factor agents (hereinafter referred to as “anti-VEGF agents”) primarily for the treatment of wet-age related macular degeneration (wAMD).

For more details, go to: http://www.pharmac.govt.nz/news/rfp-2016-05-05-antivascular-endothelial-growth-factor/